ISELIN, New Jersey, November 26, 2012 /PRNewswire/ --
Ansell, a global leader in protection solutions, today announced the extension of its market-leading antimicrobial technology product range, to include non-latex surgical gloves. The advanced GAMMEX ® Non-Latex Antimicrobial  ,  surgical glove is now available in Canada, with broader roll-out to follow.
Ansell first launched its unique and proprietary AMT™ Antimicrobial Technology, to industry acclaim, in Australia in 2010, with the GAMMEX Powder-Free with AMT Antimicrobial Technology surgical glove. Today, Ansell is building on this success and extending its antimicrobial technology range to include a latex-free surgical glove, another new to the world medical device.
The GAMMEX Non-Latex Antimicrobial surgical glove provides a new level of protection for healthcare workers, protecting not only against latex (Type I) allergies, but against microbial transmission due to intraoperative glove breaches. Up to 83% of glove breaches go unnoticed by surgeons, further increasing the risk of contamination.*The glove's antimicrobial chlorhexidine gluconate (CHG) coating is effective against 99% of the Hepatitis C virus, HIV-1 strain Mn and six common infectious bacteria, including drug-resistant MRSA . " The GAMMEX Non-Latex Antimicrobial surgical glove is another indication of our commitment to develop clinically relevant products in anticipation of healthcare workers' needs," said Anthony B. Lopez, President and General Business Manager, Ansell Medical Solutions. "Our relentless focus on innovation is evident in the new products and technologies we launch aimed at providing the utmost protection for healthcare workers and patients alike." The GAMMEX brand is the global brand leader in surgical gloves, with more than 100 million pairs used annually in hospitals worldwide. The GAMMEX product range incorporates cutting-edge technologies to provide a wide range of advanced protection solutions for healthcare professionals. Today, Ansell takes this protection to a new level and sets a new standard for infection prevention in the global healthcare industry.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV